Intuitive Surgical increases share repurchase program by additional $1B Intuitive Surgical announced that its board has authorized the company to repurchase an additional $1B of the company's outstanding common stock. The $1B repurchase authorization will be available after the company's internal trading window opens on April 23. With this authorization, the total amount available for share repurchases by the company is approximately $1.21B, which includes approximately $208M remaining from previous authorizations. The company expects to fund the repurchase program through cash and investments. As of December 31, the company had approximately $2.9B of cash, cash equivalents and investments.
Intuitive Surgical initiated with a Neutral at Piper Jaffray Piper Jaffray analyst Matt O'Brien started shares of Intuitive Surgical with a Neutral rating and $505 price target. O'Brien calls the stock "simply too expensive" relative to expected sales and earnings, but admits Intuitive's robotic surgical technology will likely dominate the market in the coming years. Further, the analyst thinks the company's da Vinci Prostatectomy and da Vinci Hysterectomy procedures could contract amid new diagnostic tests and insurance pushback. The stock closed yesterday up $2.05 to $496.37.